Personalized drug dosage with breath analysis demonstrated in a clinical setting

science
Written By Guest User

This publication by Kapil Dev Singh, Pablo Sinues, and colleagues is a milestone in the path to bring breath analysis applications to the clinic.
Converting data to knowledge can be a daunting task because breath samples are complex. This gap has been bridged with high-quality data and advanced metabolomics data analysis techniques.

This study uses the Super SESI™ - Exhalion™ - Q Exactive™ platform developed by Fossiliontech on top of Thermo Scientific Orbitrap™.
We are proud of the work scientists are doing with our technology. We feel their success is our success as well.

“If I have seen further, it is by standing on the shoulders of giants.” Isaac Newton, 1675. Some giants and pioneers worth mentioning on the technology development side: Renato Zenobi (ETH Zürich), Juan F. de la Mora (Yale University), Alexander Makarov (Thermo Fisher Scientific), J. B. Fenn.

Links of interest:
The publication: nature.com/articles/s43856-021-00021-3
Super SESI: fossiliontech.com/super-sesi-for-thermo
Exhalion: fossiliontech.com/exhalion
Breath analysis technology: fossiliontech.com/breath-analysis
SESI on Wikipedia: en.wikipedia.org/wiki/Secondary_electrospray_ionization

#breathanalysis #Orbitrap #SUPERSESI #datascience #research #digitalhealth #metabolomics #technologydevelopment

Guest User
Previous

SUPER SESI for headspace analysis of experimental animals.
Next

The excellent research on breath analysis lead by Prof. Dr. Malcolm Kohler and his team at USZ will now have an even higher throughput.